Qiagen NV produces biomedical and genetic products, products for separating and purifying nucleic acids for gene-based drug screening, nucleic acid-based clinical diagnostics, genetic vaccination and gene therapy.
Analysis/Commentary Strong EPS and Sales Growth Y-on-Y
Based on the study of the previous quarterly earnings reports and subsequent price moves: - Current quarter has started well, however, we have an opportunity for pull-back now and entry - Looking for a price closer to the LOW point, confirmed by Slo Stochastic - Expectation for the price to then move to MID or HIGH point - Trailing stop-loss on price above MID point
GOOD LUCK. DO YOUR OWN RESEARCH!
Comment
⋅
TRADE UPDATE: Unsuccessful Further analysis to follow for learning